EP
IDXX icon

Eudaimonia Partners’s Idexx Laboratories IDXX Stock Holding History

Eudaimonia Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-123
Closed -$60K – 821
2021
Q1 		$60K Sell
123
-25
-17% -$12.5K 0.01% 588
2020
Q4 		$74K Hold
148
– – 0.02% 515
2020
Q3 		$58K Hold
148
– – 0.01% 525
2020
Q2 		$49K Hold
148
– – 0.02% 509
2020
Q1 		$36K Hold
148
– – 0.02% 534
2019
Q4 		$39K Buy
+148
New +$39K 0.02% 542

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Eudaimonia Partners's IDXX Position: Q2 2021 in Review

Eudaimonia Partners sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 123 shares — an estimated $60K sold.

Eudaimonia Partners first reported a position in IDXX in Q4 2019 and held it in 6 quarters. The position peaked at $74K in Q4 2020. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Eudaimonia Partners reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 123 Idexx Laboratories shares in Q2 2021, an estimated $60K.
  • Eudaimonia Partners first reported a position in Idexx Laboratories in Q4 2019 and held it in 6 quarters.
  • Eudaimonia Partners's Idexx Laboratories position peaked at $74K in Q4 2020.
  • 1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.